Ffcm LLC Raises Holdings in Colgate-Palmolive (CL)

Ffcm LLC grew its position in Colgate-Palmolive (NYSE:CL) by 5.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 53,228 shares of the company’s stock after purchasing an additional 2,542 shares during the period. Ffcm LLC’s holdings in Colgate-Palmolive were worth $3,878,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the business. Pacer Advisors Inc. boosted its stake in shares of Colgate-Palmolive by 8.4% during the 2nd quarter. Pacer Advisors Inc. now owns 20,224 shares of the company’s stock worth $1,499,000 after acquiring an additional 1,566 shares in the last quarter. Fiduciary Trust Co. boosted its stake in shares of Colgate-Palmolive by 1.6% during the 2nd quarter. Fiduciary Trust Co. now owns 170,818 shares of the company’s stock worth $12,663,000 after acquiring an additional 2,758 shares in the last quarter. The Manufacturers Life Insurance Company boosted its stake in shares of Colgate-Palmolive by 10.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,131,987 shares of the company’s stock worth $83,914,000 after acquiring an additional 105,878 shares in the last quarter. Pensionfund DSM Netherlands bought a new stake in shares of Colgate-Palmolive during the 3rd quarter worth about $4,225,000. Finally, Pacad Investment Ltd. bought a new stake in shares of Colgate-Palmolive during the 2nd quarter worth about $549,000. 72.83% of the stock is currently owned by institutional investors.

Shares of Colgate-Palmolive (NYSE CL) opened at $75.53 on Tuesday. Colgate-Palmolive has a 52 week low of $63.43 and a 52 week high of $77.27. The firm has a market capitalization of $66,320.00, a P/E ratio of 29.16, a P/E/G ratio of 3.21 and a beta of 0.81. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, meeting the consensus estimate of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The firm had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter in the prior year, the company earned $0.73 EPS. The firm’s revenue for the quarter was up 2.8% compared to the same quarter last year. equities analysts forecast that Colgate-Palmolive will post 2.88 earnings per share for the current year.

In other Colgate-Palmolive news, insider Victoria L. Dolan sold 9,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $73.41, for a total value of $660,690.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Jennifer Daniels sold 7,375 shares of the firm’s stock in a transaction that occurred on Wednesday, December 13th. The stock was sold at an average price of $73.18, for a total value of $539,702.50. Following the completion of the sale, the insider now owns 38,691 shares of the company’s stock, valued at approximately $2,831,407.38. The disclosure for this sale can be found here. Insiders sold a total of 181,048 shares of company stock valued at $13,168,995 in the last quarter. Corporate insiders own 1.02% of the company’s stock.

Several research firms have recently issued reports on CL. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $84.00 price target for the company in a research note on Monday. Macquarie upgraded Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price target for the company in a research note on Tuesday, December 19th. Deutsche Bank began coverage on Colgate-Palmolive in a research note on Wednesday, December 13th. They set a “hold” rating and a $75.00 price target for the company. Societe Generale downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 target price for the company. in a research note on Wednesday, November 29th. They noted that the move was a valuation call. Finally, KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a research note on Saturday, November 25th. Two equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and six have issued a buy rating to the company’s stock. Colgate-Palmolive presently has an average rating of “Hold” and an average target price of $76.51.

ILLEGAL ACTIVITY NOTICE: “Ffcm LLC Raises Holdings in Colgate-Palmolive (CL)” was posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece of content on another website, it was copied illegally and republished in violation of United States and international trademark and copyright law. The original version of this piece of content can be read at https://www.com-unik.info/2018/01/09/ffcm-llc-raises-holdings-in-colgate-palmolive-cl.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit